News
PIF TICK quality mark for health information
PIF TICK is the UK’s only assessed quality mark for printed and online health and care information. Following our recent annual assessment, Lymphoma Action had confirmation that we continue to meet the high standards required for PIF TICK accreditation. PIF TICK was introduced by the Patient Information Forum (PIF) as a way of helping people easily identify information as evidence-based, up-to-date and easy to use and understand. You can visit our website to find out more about PIF TICK, our approach to health information and see our full range of books and online information.
Next year - celebrating 40 years
2026 will be a special year for Lymphoma Action as we celebrate our 40th anniversary! We are proud to have been supporting people affected by lymphoma for four decades and will be looking back at our achievements, as well as looking forward to the future. We couldn’t do what we do without our amazing community, so we hope you will join us in marking the occasion. More information to come soon – keep an eye on our emails and website.
Best Practice Timed Pathway for blood cancers
Lymphoma Action, in partnership with Leukaemia UK and Myeloma UK, is proud to be working with the NHS England Cancer Programme to create the first Best Practice Timed Pathway (BPTP) for blood cancers.
A BPTP is a structured guide for healthcare professionals, outlining the diagnostic tests and timeframes for a patient’s journey from suspected cancer to the start of treatment. The new pathway is designed to help meet the 28-day faster diagnosis standard, which aims to ensure patients receive a diagnosis or have cancer ruled out within 28 days.
“We're proud to be at the forefront of developing the very first BPTP for blood cancers, working with the NHS and our charity partners. The new pathway won’t just make things better for people with lymphoma, it will also set up important foundations for future healthcare improvements across the country.
Ropinder Gill, CEO, Lymphoma Action
This initiative is expected to significantly improve care and outcomes for people with lymphoma, leukaemia and myeloma, building on the success of similar pathways already in place for other cancers.
Our latest podcast: Finding a safe space
In our latest podcast Nancy, who has lymphoma, and Stewart, CEO of the organisation OUTpatients, talk to Lymphoma Action’s Dallas Pounds.
They both share their personal blood cancer experiences as LGBTQIA+ people and describe the additional challenges they faced. Stewart explains why he set up the charity OUTpatients and how they seek to support LGBT+ people with cancer and after treatment.
